Markets:

Overview

News

Currencies

International

Treasuries

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amneal Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Earnings Scheduled For November 4, 2022 ↗

November 04, 2022

Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $0.49 per share on revenue of $49.95 million. • Telefonica (NYSE:TEF) is likely to report earnings for...

Via Benzinga

Amneal Seeks FDA Approval For Its Parkinson's Candidate ↗

September 01, 2022

Via Benzinga

Amneal Pharma Posts Mixed Q2 Earnings, Cuts Profit Outlook For 2022 ↗

August 05, 2022

Via Benzinga

Recap: Amneal Pharmaceuticals Q2 Earnings ↗

August 05, 2022

Amneal Pharmaceuticals (NYSE:AMRX) reported its Q2 earnings results on Friday, August 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Amneal Pharmaceuticals Q1 Earnings ↗

May 04, 2022

Amneal Pharmaceuticals (NYSE:AMRX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Outlook For Amneal Pharmaceuticals ↗

November 03, 2022

Amneal Pharmaceuticals (NYSE:AMRX) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement. Analysts estimate that Amneal...

Via Benzinga

Amneal Receives FDA Approval for Leuprolide Acetate Injection

November 02, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Expands Leadership Team with Appointment of Senior Leaders in Quality and Regulatory

October 31, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Report Third Quarter 2022 Results on November 4, 2022

October 06, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Launches First Biosimilar with ALYMSYS® (bevacizumab-maly) in the United States

October 03, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty

September 06, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 31, 2022

Gainers

Via Benzinga

Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease

August 31, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal supports Congress’ efforts to ensure essential medicines are Made in America

August 22, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal launches 4 new Generic products, including Vasopressin single-dose

August 11, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

August 11, 2022

On Thursday, 22 companies reached new 52-week lows.

Via Benzinga

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Amneal Reports Second Quarter 2022 Financial Results

August 05, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

Amneal Pharmaceuticals's Earnings: A Preview ↗

August 04, 2022

Amneal Pharmaceuticals (NYSE:AMRX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Amneal...

Via Benzinga

Amneal Appoints Deborah M. Autor to Board of Directors

August 03, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Report Second Quarter 2022 Results on August 5, 2022

July 08, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Releases 2021 Corporate Responsibility Report Highlighting Continued ESG Impact and Integration

June 07, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Launches LYVISPAH® (baclofen) for Spasticity Related to Multiple Sclerosis and Other Spinal Cord Disorders

June 01, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk)

May 27, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Participate at the 2022 Jefferies Healthcare Conference

May 24, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal to Participate at Upcoming Investor Conferences in May

May 13, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗

May 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Amneal Reports First Quarter 2022 Financial Results

May 04, 2022

From Amneal Pharmaceuticals, Inc.

Via Business Wire

Amneal Pharmaceuticals's Earnings Outlook ↗

May 03, 2022

Amneal Pharmaceuticals (NYSE:AMRX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NY:AMRX)

All News about Amneal Pharmaceuticals, Inc. - Class A Common Stock

Starting at /week.